Paget-Schroetter综合征延迟第一肋切除的中期结果
本研究回顾性分析19例Paget-Schroetter综合征患者,采用单纯抗凝后延迟3-6个月行第一肋切除、不做溶栓的简化方案。术后 duplex 显示16例血栓完全溶解,平均随访20.3个月时17例无症状,提示该方案可有效缓解症状并简化管理。
要点
- 单纯抗凝后延迟第一肋切除可有效缓解Paget-Schroetter综合征症状。
- 避免溶栓可能降低风险与费用,同时保持良好短期结局。
- 部分患者仍需术中或术后经皮腔内静脉成形术处理狭窄。
核心结论
- 抗凝后延迟第一肋切除可提供有效的短期症状缓解。
- 避免溶栓简化了管理,可能降低风险与费用且结局良好。
研究设计与样本
- 回顾性队列研究,纳入2017年1月至2024年7月因Paget-Schroetter综合征行第一肋切除的患者,使用前瞻性维护数据库。
- 共识别27例,排除8例接受溶栓者,最终分析19例(平均年龄28.4岁,13例男性)。
主要发现
- 所有19例均表现为手臂肿胀和疼痛,锁骨下静脉受累15例,腋静脉受累4例。
- 术后 duplex 显示16例DVT完全溶解,3例部分或慢性DVT。
- 4例因症状性狭窄需术中经皮腔内静脉成形术。
- 平均随访20.3±22.1个月,17例无症状,2例需额外经皮腔内静脉成形术。
临床怎么用
- 对于Paget-Schroetter综合征,可考虑单纯抗凝后延迟3-6个月行第一肋切除,不做溶栓。
- 术后需用 duplex 评估血栓溶解情况,症状性狭窄可行经皮腔内静脉成形术。
局限性
- 回顾性研究,样本量小(19例)。
- 随访时间有限,需进一步研究评估长期疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The standard treatment for axillosubclavian deep venous thrombosis (DVT) in patients with Paget-Schroetter syndrome typically includes thrombolysis, first rib resection (FRR), and, when needed, percutaneous transluminal venoplasty (PTV) or stenting. Our institution adopted a simplified approach using anticoagulation alone followed by delayed FRR (3-6 months) without thrombolysis. This study evaluates its clinical effectiveness. METHODS: We conducted a retrospective cohort study of patients who underwent FRR for upper-extremity DVT in Paget-Schroetter syndrome between January 2017 and July 2024, using a prospectively maintained database. The primary end point was postoperative clinical improvement. We also analyzed patient demographics, venous involvement, hypercoagulable status, and anticoagulation duration. RESULTS: Of 27 identified patients, eight who underwent thrombolysis were excluded. Among the 19 patients (mean age, 28.4 years; 13 males), all presented with arm swelling and pain. The subclavian vein was involved in 15 patients and the axillary vein in four. Eleven patients were involved in competitive sports. Mean preoperative anticoagulation duration was 5.9 ± 2.1 months and was discontinued postoperatively. Most patients underwent transaxillary FRR. Postoperative duplex showed complete DVT resolution in 16 patients and partial or chronic DVT in three. Four patients required intraoperative PTV for symptomatic stenosis. At a mean follow-up of 20.3 ± 22.1 months, 17 patients were symptom-free, whereas two patients required additional PTV. CONCLUSIONS: Anticoagulation followed by delayed FRR provides effective short-term symptom relief. Avoiding thrombolysis simplifies management and may reduce risks and costs while maintaining favorable outcomes. Further studies are needed to assess long-term efficacy.
引用
- Alkhani M, Alshehri A, Al-Saadi M, et al. Midterm outcomes after delayed first rib resection for acute axillosubclavian deep vein thrombosis in Paget-Schroetter syndrome. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42732805. doi:10.1016/j.jvsv.2026.102622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。